Through the collaboration of women and scientists across the globe, our vision is to predict and prevent the major diseases of late pregnancy. With the valued participation of women around the world, the SCOPE study is establishing a unique pregnancy biobank for scientific discovery to develop tests that predict these conditions.

SCOPE Ireland recruited the 4000th participant into the SCOPE study; 4000 nulliparous women in NZ, Australia, the UK and Ireland are now participating in SCOPE.